Oncology & Cancer

Treating tumors with engineered dendritic cells

Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center (Heidelberg) have developed a novel immunotherapy that does not require knowledge of a tumor's antigenic makeup. The new results may pave the way to ...

Oncology & Cancer

Hodgkin's lymphoma: Small changes in cells, big effect

Hodgkin's lymphoma is one of the most common types of lymphoma in young adults. It is characterized by the presence of enlarged B lymphocytes, which are unusual in that they bear on their surface the identifying markers of ...

Immunology

Unveiling a novel immune response in the intestinal epithelium

Researchers from the Jan Dobeš laboratory at Charles University in Prague have made a significant discovery uncovering a novel immune response in the intestinal epithelium. Furthermore, their study delineates a mechanism ...

Immunology

Can science take the STING out of runaway inflammation?

Until the COVID-19 pandemic exploded, few people outside of research labs and intensive care units had heard of a cytokine storm. But once this dangerous form of infection-triggered runaway inflammation started claiming lives ...

page 5 from 40